Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity

• Franziska Sotzny,
• Igor Salerno Filgueiras,
• Claudia Kedor,
• Helma Freitag,
• Kirsten Wittke,
• Sandra Bauer,
• Nuno Sepúlveda,
• Nuno Sepúlveda,
• Dennyson Leandro Mathias da Fonseca,
• Gabriela Crispim Baiocchi,
• Alexandre H. C. Marques,
• Myungjin Kim,
• Tanja Lange,
• Desirée Rodrigues Plaça,
• Finn Luebber,
• Finn Luebber,
• Frieder M. Paulus,
• Roberta De Vito,
• Igor Jurisica,
• Igor Jurisica,
• Igor Jurisica,
• Igor Jurisica,
• Igor Jurisica,
• Kai Schulze-Forster,
• Friedemann Paul,
• Friedemann Paul,
• Friedemann Paul,
• Friedemann Paul,
• Judith Bellmann-Strobl,
• Judith Bellmann-Strobl,
• Judith Bellmann-Strobl,
• Judith Bellmann-Strobl,
• Rebekka Rust,
• Rebekka Rust,
• Rebekka Rust,
• Rebekka Rust,
• Uta Hoppmann,
• Uta Hoppmann,
• Uta Hoppmann,
• Uta Hoppmann,
• Yehuda Shoenfeld,
• Yehuda Shoenfeld,
• Gabriela Riemekasten,
• Harald Heidecke,
• Otavio Cabral-Marques,
• Otavio Cabral-Marques,
• Otavio Cabral-Marques,
• Otavio Cabral-Marques,
• Otavio Cabral-Marques,
• Carmen Scheibenbogen

Affiliations

Franziska Sotzny

Institute for Medical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany

Igor Salerno Filgueiras

Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil

Claudia Kedor

Institute for Medical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany

Helma Freitag

Institute for Medical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany

Kirsten Wittke

Institute for Medical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany

Sandra Bauer

Institute for Medical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany

Nuno Sepúlveda

Faculty of Mathematics and Information Science, Warsaw University of Technology, Warsaw, Poland

Nuno Sepúlveda

CEAUL – Centro de Estatística e Aplicações da Universidade de Lisboa, Lisbon, Portugal

Dennyson Leandro Mathias da Fonseca

Interunit PostGraduate Program on Bioinformatics, Institute of Mathematics and Statistics (IME), University of Sao Paulo, Sao Paulo, Brazil

Gabriela Crispim Baiocchi

Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil

Alexandre H. C. Marques

Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil

Myungjin Kim

Data Science Initiative, Brown University, Providence, RI, United States

Tanja Lange

Department of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, Germany

Desirée Rodrigues Plaça

Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil

Finn Luebber

Department of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, Germany

Finn Luebber

Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany

Frieder M. Paulus

Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany

Roberta De Vito

0Department of Biostatistics and the Data Science Initiative, Brown University, Providence, RI, United States

Igor Jurisica

1Osteoarthritis Research Program, Division of Orthopedic Surgery, Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada

Igor Jurisica

2Data Science Discovery Centre for Chronic Diseases, Krembil Research Institute, University Health Network, Toronto, ON, Canada

Igor Jurisica

3Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada

Igor Jurisica

4Department of Computer Science, University of Toronto, Toronto, ON, Canada

Igor Jurisica

5Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia

Kai Schulze-Forster

6CellTrend GmbH, Luckenwalde, Germany

Friedemann Paul

7Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany

Friedemann Paul

8Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany

Friedemann Paul

9Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany

Friedemann Paul

0NeuroCure Clinical Research Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Judith Bellmann-Strobl

Institute for Medical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany

Judith Bellmann-Strobl

7Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany

Judith Bellmann-Strobl

8Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany

Judith Bellmann-Strobl

9Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany

Rebekka Rust

Institute for Medical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany

Rebekka Rust

7Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany

Rebekka Rust

8Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany

Rebekka Rust

9Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany

Uta Hoppmann

Institute for Medical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany

Uta Hoppmann

7Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany

Uta Hoppmann

8Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany

Uta Hoppmann

9Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany

Yehuda Shoenfeld

1Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Affiliated with the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Hashomer, Israel

Yehuda Shoenfeld

2Ariel University, Ariel, Israel

Gabriela Riemekasten

Department of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, Germany

Harald Heidecke

6CellTrend GmbH, Luckenwalde, Germany

Otavio Cabral-Marques

Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil

Otavio Cabral-Marques

Interunit PostGraduate Program on Bioinformatics, Institute of Mathematics and Statistics (IME), University of Sao Paulo, Sao Paulo, Brazil

Otavio Cabral-Marques

Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil

Otavio Cabral-Marques

3Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Sao Paulo, Brazil

Otavio Cabral-Marques

4Department of Pharmacy, Federal University of Rio Grande do Norte, Natal, RN, Brazil

Carmen Scheibenbogen

Institute for Medical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany